Renivace and aspartate aminotransferase increased Patient Reports February 13, 2012

Renivace Side Effects Report #5162019-5
Renivace side effect was reported by a Physician from JAPAN on Nov 07, 2006. Male patient, 73 years of age, weighting 163.1 lb, was diagnosed with myocardial infarction, gastric ulcer haemorrhage, sepsis  and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, chills, cholelithiasis, gamma-glutamyltransferase increased, hepatic infiltration eosinophilic, liver disorder, pyrexia. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with GASTER, GASTER D, PAZUCROSS, PANALDINE, ARTIST, ASPIRIN, SIGMART. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5200966-6
Renivace side effect was reported by a Physician from JAPAN on Dec 15, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with hypertension, thrombosis prophylaxis, diabetes mellitus non-insulin-dependent, gastric ulcer and was treated with Renivace. After drug was administered, patient experienced the following side effects: acute myocardial infarction, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood immunoglobulin e increased, blood lactate dehydrogenase increased, c-reactive protein increased, interstitial lung disease, lymphocyte stimulation test positive. Renivace dosage: 5 MG QD PO. During the same period patient was treated with BUFFERIN, EUGLUCON, OMEPRAL, PANALDINE, DIOVAN. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5143257-4
Renivace side effect was reported by a Physician from JAPAN on Oct 13, 2006. Male patient, 73 years of age, weighting 163.1 lb, was diagnosed with hypertension, gastric ulcer, gastric ulcer haemorrhage, sepsis , angina pectoris, myocardial infarction and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gastric ulcer haemorrhage, hepatic infiltration eosinophilic, liver disorder. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with FAMOTIDINE, GASTER D, PAZUCROSS, PANALDINE, ARTIST, ASPIRIN, SIGMART. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5584657-8
Renivace side effect was reported by a Physician from JAPAN on Dec 18, 2007. Male patient, 71 years of age, was diagnosed with hypertension, prophylaxis and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, international normalised ratio increased, liver disorder, prothrombin time prolonged. Renivace dosage: (5 MG QD ORAL). During the same period patient was treated with BAYASPIRIN, WARFARIN, DIGOXIN, MUCOSTA, MAGNESIUM OXIDE, GLYSENNID. Patient recovered.


Renivace Side Effects Report #5085260-9
Renivace side effect was reported by a Physician from ALBANIA on July 31, 2006. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with hypertension, angina pectoris, coronary arterial stent insertion, hyperlipidaemia, hypertonia and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test, lymphocyte stimulation test positive. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with PANALDINE, LIVALO, SIGMART, CALBLOCK, ARTIST. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5102516-1
Renivace side effect was reported by a Physician from JAPAN on Aug 23, 2006. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with hypertension, angina pectoris, coronary arterial stent insertion, hyperlipidaemia, hypertonia and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test positive. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with PANALDINE, LIVALO, SIGMART, CALBLOCK, ARTIST. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5050441-7
Renivace side effect was reported by a Physician from JAPAN on June 21, 2006. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease recurrence, dysphonia, eosinophil percentage decreased, face oedema. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, DILTIAZEM. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4705683-4
Renivace side effect was reported by a Physician from on June 10, 2005. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease recurrence, dysphonia, eosinophil percentage decreased, gamma-glutamyltransferase increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, HERBERSSER R. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4717263-5
Renivace side effect was reported by a Physician from JAPAN on June 29, 2005. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, dysphonia, eosinophil percentage decreased, gamma-glutamyltransferase increased, laryngeal oedema. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, DILTIAZEM. Patient was hospitalized. Patient recovered.


Renivace Side Effects Report #4733538-8
Renivace side effect was reported by a Physician from JAPAN on July 13, 2005. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease recurrence, dysphonia, eosinophil count decreased, gamma-glutamyltransferase increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, DILTIAZEM. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4746491-8
Renivace side effect was reported by a Physician from JAPAN on July 29, 2005. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease recurrence, dysphonia, eosinophil count decreased, gamma-glutamyltransferase increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, DILTIAZEM. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5146308-6
Renivace side effect was reported by a Pharmacist from JAPAN on Oct 17, 2006. Female patient was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood lactate dehydrogenase increased, chromaturia, gamma-glutamyltransferase increased, hepatic function abnormal. Renivace dosage: 2.5 MG Q DAY PO. Patient recovered.

Renivace Side Effects Report #5141845-2
Renivace side effect was reported by a Physician from JAPAN on Oct 10, 2006. Female patient, 80 years of age, was diagnosed with cardiac failure, hypertension, hyperuricaemia, constipation  and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, platelet count decreased, stevens-johnson syndrome, white blood cell count decreased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ALLOPURINOL, ADALAT, PURSENNID, LASIX. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5402039-6
Renivace side effect was reported by a Physician from JAPAN on July 11, 2007. Male patient, 70 years of age, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, leukopenia. Renivace dosage: 2.5 MG QD ORAL. During the same period patient was treated with EPALRESTAT, LASIX. Patient was hospitalized. Patient recovered.


Renivace Side Effects Report #5413418-5
Renivace side effect was reported by a Consumer or non-health professional from JAPAN on July 25, 2007. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with cardiac failure, diabetic neuropathy and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hypokalaemia, leukopenia, neutrophil count decreased. Renivace dosage: (2.5 MG QD ORAL). During the same period patient was treated with EPALRESTAT, ALDACTONE, ARTIST, DIGOSIN, LASIX, WARFARIN POTASSIUM. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5447432-0
Renivace side effect was reported by a Physician from JAPAN on Aug 20, 2007. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with cardiac failure, diabetic neuropathy and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diabetic neuropathy, granulocytopenia, hepatic enzyme increased, hypokalaemia, leukopenia, monocyte percentage increased, neutrophil percentage decreased. Renivace dosage: (2.5 MG QD ORAL). During the same period patient was treated with EPALRESTAT, SPIRONOLACTONE, ALDACTONE, ARTIST, DIGOSIN, LASIX, WARFARIN POTASSIUM. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4715569-7
Renivace side effect was reported by a Physician from JAPAN on June 27, 2005. Female patient, 19 years of age, weighting 66.14 lb, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: anuria, aspartate aminotransferase increased, beta-n-acetyl-d-glucosaminidase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride decreased, blood lactate dehydrogenase increased, blood potassium increased, blood pressure systolic decreased. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with MILRILA, LASIX, ALDACTONE, HALFDIGOXIN, NEUQUINONE, ZYLORIC. Patient recovered.

Renivace Side Effects Report #4591098-9
Renivace side effect was reported by a Physician from on Feb 02, 2005. Male patient, 76 years of age, was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine decreased, blood lactate dehydrogenase increased, condition aggravated, haematocrit decreased, haemoglobin decreased, interstitial lung disease, pneumonia aspiration. Renivace dosage: 1.25 MG Q DAY PO. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, GASTER, VITAMIN ADDITIVE, BISOLVON. Patient died on 10/08/2004.